Trump hails judge's ruling against Obamacare as 'great'

President Donald Trump on Saturday hailed a court decision against Obamacare as "a great ruling for our country," while a U.S. government official said the decision by a Texas judge would have no immediate impact on health coverage.

Evofem's birth control gel meets main study goal; shares rise

Evofem Biosciences Inc said on Monday its birth control gel showed effectiveness in preventing pregnancy in a late-stage study, paving the way for potential approval of the first hormone-free contraceptive gel and sending its shares up 17 percent before the bell.

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial

Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a late-stage trial.

Nicox teams up with Chinese firm to develop and sell glaucoma drug

French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.

E-cigarette usage nearly doubles in U.S. high-schools: survey

The percentage of high school seniors who used e-cigarettes in the last 30 days nearly doubled to 20.9 percent from last year, results of a survey released by the National Institute on Drug Abuse showed on Monday.

China confirms new African swine fever cases in Sichuan, Heilongjiang

China confirmed two new cases of African swine fever, as the disease continues to spread through the world's largest hog herd, the Ministry of Agriculture and Rural Affairs said late on Sunday in a statement on its website.

Study finds chronic fatigue clues in overactive immune response

Scientists exploring what may trigger a complex disorder known as chronic fatigue syndrome (CFS) have found clues in the way some people's immune systems respond more actively to a health attack.

Special Report: J&J knew for decades that asbestos lurked in its Baby Powder

Darlene Coker knew she was dying. She just wanted to know why.

J&J kept a guiding hand on talc safety research

Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

J&J shares nosedive on report it knew of asbestos in Baby Powder

Shares of Johnson & Johnson fell 10 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Powder.

Flu shots tied to lower risk of premature death with heart failure

(Reuters Health) - - People with heart failure who get flu shots may be less likely to die prematurely than their counterparts who don't get vaccinated, a Danish study suggests.

Related Videos

Grammy nominations focus on diversity

Kevin Hart quits as Oscar host over old tweets

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS